Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

A Basic Study of Photodynamic Therapy with Glucose-Conjugated Chlorin e6 Using Mammary Carcinoma Xenografts.

Osaki T, Hibino S, Yokoe I, Yamaguchi H, Nomoto A, Yano S, Mikata Y, Tanaka M, Kataoka H, Okamoto Y.

Cancers (Basel). 2019 May 8;11(5). pii: E636. doi: 10.3390/cancers11050636.

2.

Efficacy of 5-Aminolevulinic Acid in Photodynamic Detection and Photodynamic Therapy in Veterinary Medicine.

Osaki T, Yokoe I, Sunden Y, Ota U, Ichikawa T, Imazato H, Ishii T, Takahashi K, Ishizuka M, Tanaka T, Li L, Yamashita M, Murahata Y, Tsuka T, Azuma K, Ito N, Imagawa T, Okamoto Y.

Cancers (Basel). 2019 Apr 7;11(4). pii: E495. doi: 10.3390/cancers11040495.

3.

Association of cardiac magnetic resonance-detected myocardial abnormalities with disease characteristics and brain natriuretic peptide levels in systemic sclerosis without cardiac symptoms.

Sugiyama K, Kobayashi H, Kobayashi Y, Yokoe I, Takei M, Kitamura N.

Int J Rheum Dis. 2019 Jun;22(6):1016-1022. doi: 10.1111/1756-185X.13540. Epub 2019 Mar 28.

PMID:
30924296
4.

Heart Rate-corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab.

Kobayashi H, Kobayashi Y, Yokoe I, Kitamura N, Nishiwaki A, Takei M, Giles JT.

J Rheumatol. 2018 Dec;45(12):1620-1627. doi: 10.3899/jrheum.180065. Epub 2018 Sep 1.

PMID:
30173151
5.

Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.

Yokoe I, Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Kitamura N, Takei M.

Scand J Rheumatol. 2018 Sep;47(5):364-370. doi: 10.1080/03009742.2017.1418424. Epub 2018 May 28.

PMID:
29804492
6.

Metformin enhances the cytotoxicity of 5-aminolevulinic acid-mediated photodynamic therapy in vitro.

Osaki T, Yokoe I, Takahashi K, Inoue K, Ishizuka M, Tanaka T, Azuma K, Murahata Y, Tsuka T, Itoh N, Imagawa T, Okamoto Y.

Oncol Lett. 2017 Jul;14(1):1049-1053. doi: 10.3892/ol.2017.6237. Epub 2017 May 24.

7.

Impact of biological treatment on left ventricular function and morphology in rheumatoid arthritis patients without cardiac symptoms, assessed by cardiac magnetic resonance imaging.

Kobayashi Y, Kobayashi H, Giles J, Yokoe I, Nishiwaki A, Takei M.

Scand J Rheumatol. 2017 Jul;46(4):328-329. doi: 10.3109/03009742.2016.1173722. Epub 2017 Feb 20. No abstract available.

PMID:
28276954
8.

Magnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels.

Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT.

Arthritis Care Res (Hoboken). 2017 Sep;69(9):1304-1311. doi: 10.1002/acr.23138. Epub 2017 Aug 8.

9.

Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168].

Osaki T, Yokoe I, Uto Y, Ishizuka M, Tanaka T, Yamanaka N, Kurahashi T, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y.

Ultrason Sonochem. 2017 Sep;38:751. doi: 10.1016/j.ultsonch.2016.06.002. Epub 2016 Jun 9. No abstract available.

PMID:
27291696
10.

Detection of Left Ventricular Regional Dysfunction and Myocardial Abnormalities Using Complementary Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis without Cardiac Symptoms: A Pilot Study.

Kobayashi Y, Kobayashi H, T Giles J, Yokoe I, Hirano M, Nakajima Y, Takei M.

Intern Med. 2016;55(3):237-43. doi: 10.2169/internalmedicine.55.4441. Epub 2016 Feb 1.

11.

Photodynamic detection of canine mammary gland tumours after oral administration of 5-aminolevulinic acid.

Osaki T, Yokoe I, Ogura S, Takahashi K, Murakami K, Inoue K, Ishizuka M, Tanaka T, Li L, Sugiyama A, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y.

Vet Comp Oncol. 2017 Sep;15(3):731-739. doi: 10.1111/vco.12213. Epub 2016 Jan 14.

PMID:
26766288
12.

[Case Report; Long-term treatment with etanercept induced systemic sarcoidosis in a patient with rheumatoid arthritis].

Yokoe I, Haraoka H, Yonamine T, Sato R, Nishiwaki A, Takei M.

Nihon Naika Gakkai Zasshi. 2015 Apr 10;104(4):769-74. Japanese. No abstract available.

PMID:
26536740
13.

Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate.

Osaki T, Yokoe I, Uto Y, Ishizuka M, Tanaka T, Yamanaka N, Kurahashi T, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y.

Ultrason Sonochem. 2016 Jan;28:161-168. doi: 10.1016/j.ultsonch.2015.07.013. Epub 2015 Jul 14. Erratum in: Ultrason Sonochem. 2017 Sep;38:751.

PMID:
26384895
14.

Clinical systemic lupeol administration for canine oral malignant melanoma.

Yokoe I, Azuma K, Hata K, Mukaiyama T, Goto T, Tsuka T, Imagawa T, Itoh N, Murahata Y, Osaki T, Minami S, Okamoto Y.

Mol Clin Oncol. 2015 Jan;3(1):89-92. Epub 2014 Oct 30.

15.

[A case of probable catastrophic antiphospholipid syndrome with multi-organ failure presenting as a transient increase of antiphospholipid antibody levels].

Sato R, Sato H, Nishiwaki A, Yokoe I, Tsuruta S, Haraoka H.

Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(3):183-8. Japanese.

16.

Systemic and local injections of lupeol inhibit tumor growth in a melanoma-bearing mouse model.

Nitta M, Azuma K, Hata K, Takahashi S, Ogiwara K, Tsuka T, Imagawa T, Yokoe I, Osaki T, Minami S, Okamoto Y.

Biomed Rep. 2013 Jul;1(4):641-645. Epub 2013 May 28.

17.

A case of adult-onset Still's disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema.

Masuyama A, Kobayashi H, Kobayashi Y, Yokoe I, Sugimura Y, Maniwa K, Sato H, Ishida T, Hatanaka Y.

Mod Rheumatol. 2013 Mar;23(2):379-85. doi: 10.1007/s10165-012-0650-9. Epub 2012 May 24.

PMID:
22623015
18.

Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks.

Yokoe I, Nishio S, Sato H, Kobayashi H.

Mod Rheumatol. 2011 Dec;21(6):710-4. doi: 10.1007/s10165-011-0474-z. Epub 2011 Jun 8. No abstract available. Erratum in: Mod Rheumatol. 2012 Aug;22(4):643.

PMID:
21656090
19.

[Case report; acute adrenal insufficiency due to bilateral adrenal hemorrhage: a case report].

Onishi T, Kanbayashi T, Yokoe I, Tsuruta S, Haraoka H.

Nihon Naika Gakkai Zasshi. 2011 Feb 10;100(2):480-2. Japanese. No abstract available.

PMID:
21400886
20.

A case of microscopic polyangiitis with giant coronary aneurysm.

Kobayashi H, Yokoe I, Murata S, Kobayashi Y.

J Rheumatol. 2011 Mar;38(3):583-4. doi: 10.3899/jrheum.100924. No abstract available.

PMID:
21362797
21.

A case of adult onset Still's disease complicated with cryptogenic organizing pneumonia.

Sato H, Yokoe I, Nishio S, Onishi T, Takao T, Kobayashi Y, Haraoka H.

Intern Med. 2011;50(3):247-51. Epub 2011 Feb 1.

22.

Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose.

Nishimura K, Nishino J, Kouchi A, Nakamura N, Nakajima S, Yokoe I, Haraoka H, Matsushita T.

Mod Rheumatol. 2011 Apr;21(2):158-63. doi: 10.1007/s10165-010-0373-8. Epub 2010 Nov 25.

PMID:
21107634
23.

Cardiac magnetic resonance imaging in polyarteritis nodosa.

Kobayashi H, Yokoe I, Hattan N, Ohta H, Nakajima Y, Kobayashi Y.

J Rheumatol. 2010 Nov;37(11):2427-9. doi: 10.3899/jrheum.100450. No abstract available.

PMID:
21041263
24.

Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study.

Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, Lima JA, Kobayashi H.

Arthritis Res Ther. 2010;12(5):R171. doi: 10.1186/ar3131. Epub 2010 Sep 13.

25.

Radical-scavenging activity and cytotoxicity of p-methoxyphenol and p-cresol dimers.

Kadoma Y, Murakami Y, Ogiwara T, Machino M, Yokoe I, Fujisawa S.

Molecules. 2010 Feb 26;15(3):1103-12. doi: 10.3390/molecules15031103.

26.

Behçet's disease initially presenting with meningitis and sudden hearing loss.

Kikuchi T, Yokoe I, Masuyama A, Maniwa K, Tsuruta S, Hatanaka Y, Haraoka H.

Intern Med. 2010;49(5):483-6. Epub 2010 Mar 1.

27.

Cardiac magnetic resonance imaging abnormalities in patients with systemic lupus erythematosus: a preliminary report.

Kobayashi H, Giles JT, Arinuma Y, Yokoe I, Hirano M, Kobayashi Y.

Mod Rheumatol. 2010 Jun;20(3):319-23. doi: 10.1007/s10165-009-0268-8. Epub 2010 Jan 27. No abstract available.

PMID:
20107855
28.

Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis.

Kobayashi H, Yokoe I, Hirano M, Nakamura T, Nakajima Y, Fontaine KR, Giles JT, Kobayashi Y.

J Rheumatol. 2009 Jan;36(1):106-12. doi: 10.3899/jrheum.080377.

PMID:
19040307
30.

A patient with Takayasu's arteritis and rheumatoid arthritis who responded to tacrolimus hydrate.

Yokoe I, Haraoka H, Harashima H.

Intern Med. 2007;46(22):1873-7. Epub 2007 Nov 16. Review.

32.

Radical-scavenging activity of natural methoxyphenols vs. synthetic ones using the induction period method.

Kadoma Y, Atsumi T, Okada N, Ishihara M, Yokoe I, Fujisawa S.

Molecules. 2007 Feb 3;12(2):130-8.

33.

Kinetic radical-scavenging activity of colchicine and tropolone.

Kadoma Y, Ishihara M, Yokoe I, Fujisawa S.

In Vivo. 2007 May-Jun;21(3):481-6.

34.

Effects of olfactory stimulation with isovaleric acid on brain activation in informed and naïve conditions: a functional MRI study.

Murata Y, Okutani F, Nakahira M, Ushida T, Ikemoto T, Yokoe I, Takeda T, Kaba H, Tani T, Ogawa Y.

Auris Nasus Larynx. 2007 Dec;34(4):465-9. Epub 2007 May 3.

PMID:
17481839
35.

Predicting the biological activities of 2-methoxyphenol antioxidants: effects of dimers.

Fujisawa S, Ishihara M, Murakami Y, Atsumi T, Kadoma Y, Yokoe I.

In Vivo. 2007 Mar-Apr;21(2):181-8.

37.

Kinetic radical-scavenging activity of melatonin.

Fujisawa S, Kadoma Y, Ishihara M, Shibuya K, Yokoe I.

In Vivo. 2006 Mar-Apr;20(2):215-20.

38.

An ortho dimer of butylated hydroxyanisole inhibits nuclear factor kappa B activation and gene expression of inflammatory cytokines in macrophages stimulated by Porphyromonas gingivalis fimbriae.

Murakami Y, Shoji M, Hirata A, Tanaka S, Hanazawa S, Yokoe I, Fujisawa S.

Arch Biochem Biophys. 2006 May 15;449(1-2):171-7. Epub 2006 Mar 3.

PMID:
16546114
39.

Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines.

Inoue K, Kulsum U, Chowdhury SA, Fujisawa S, Ishihara M, Yokoe I, Sakagami H.

Anticancer Res. 2005 Nov-Dec;25(6B):4053-9.

40.

Ferulic acid dimer inhibits lipopolysaccharide-stimulated cyclooxygenase-2 expression in macrophages.

Hirata A, Murakami Y, Atsumi T, Shoji M, Ogiwara T, Shibuya K, Ito S, Yokoe I, Fujisawa S.

In Vivo. 2005 Sep-Oct;19(5):849-53.

41.

Cytotoxic activity of styrylchromones against human tumor cell lines.

Momoi K, Sugita Y, Ishihara M, Satoh K, Kikuchi H, Hashimoto K, Yokoe I, Nishikawa H, Fujisawa S, Sakagami H.

In Vivo. 2005 Jan-Feb;19(1):157-63.

42.

Dehydrodiisoeugenol, an isoeugenol dimer, inhibits lipopolysaccharide-stimulated nuclear factor kappa B activation and cyclooxygenase-2 expression in macrophages.

Murakami Y, Shoji M, Hirata A, Tanaka S, Yokoe I, Fujisawa S.

Arch Biochem Biophys. 2005 Feb 15;434(2):326-32.

PMID:
15639233
43.

Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers.

Fujisawa S, Atsumi T, Kadoma Y, Ishihara M, Ito S, Yokoe I.

Anticancer Res. 2004 Sep-Oct;24(5A):3019-26.

44.

Dipalmitoylphosphatidylcholine (DPPC) and DPPC/cholesterol liposomes as predictors of the cytotoxicity of bis-GMA related compounds.

Fujisawa S, Kadoma Y, Ishihara M, Atsumi T, Yokoe I.

J Liposome Res. 2004;14(1-2):39-49.

PMID:
15461931
45.

Radical-scavenging activity of butylated hydroxytoluene (BHT) and its metabolites.

Fujisawa S, Kadoma Y, Yokoe I.

Chem Phys Lipids. 2004 Jul;130(2):189-95.

PMID:
15172835
46.

Pituitary stalk metastasis from breast cancer treated with systemic chemotherapy.

Murata Y, Ogawa Y, Yokoe I, Kariya S, Morio K, Sasaki T, Nishioka A, Yoshida S.

Oncol Rep. 2003 Nov-Dec;10(6):1973-5.

PMID:
14534728
47.

Cytotoxic activity of 2-aminomethylene-3(2H)-benzofuranones against human oral tumor cell lines.

Terasawa K, Sugita Y, Yokoe I, Fujisawa S, Sakagami H.

Anticancer Res. 2001 Sep-Oct;21(5):3371-5.

PMID:
11848496
48.

Cytotoxic activity of benzothiepins against human oral tumor cell lines.

Sugita Y, Hosoya H, Terasawa K, Yokoe I, Fujisawa S, Sakagami H.

Anticancer Res. 2001 Jul-Aug;21(4A):2629-32.

PMID:
11724331
49.

Radical production and cytotoxic activity of tert-butyl-substituted phenols.

Saito M, Atsumi T, Satoh K, Ishihara M, Iwakura I, Sakagami H, Yokoe I, Fujisawa S.

In Vitr Mol Toxicol. 2001 Spring;14(1):53-63.

PMID:
11689156
50.

Cytotoxic activity of 5-benzoylimidazole and related compounds against human oral tumor cell lines.

Terasawa K, Sugita Y, Yokoe I, Fujisawa S, Sakagami H.

Anticancer Res. 2001 Mar-Apr;21(2A):1081-6.

PMID:
11396143

Supplemental Content

Support Center